Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CRHBP | P24387 | 2/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | KMO | O15229 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4332773 | 0.78 | ALDH1A1 (0.75) | ALDH1A1CRHBPCRHR2EGFRMAOA | |
| SCHEMBL481505 | 0.78 | ALDH1A1 (0.75) | ALDH1A1CRHBPCRHR2EGFRMAOA | |
| SCHEMBL8452262 | 0.78 | ALDH1A1 (0.75) | ALDH1A1CRHBPCRHR2EGFRMAOA | |
| SCHEMBL8035535 | 0.75 | ALDH1A1 (0.45) | ALDH1A1CRHBPCRHR2EGFRMAOA | |
| SCHEMBL5321294 | 0.74 | ALDH1A1 (0.69) | ALDH1A1CRHBPCRHR2EGFRMAOA | |
| SCHEMBL5130299 | 0.74 | ALDH1A1 (0.69) | ALDH1A1CRHBPCRHR2EGFRMAOA | |
| SCHEMBL29554408 | 0.74 | ALDH1A1 (0.69) | ALDH1A1CRHBPCRHR2EGFRMAOA | |
| SCHEMBL4138168 | 0.73 | ALDH1A1 (0.56) | ALDH1A1CRHBPCRHR2EGFRMAOA | |
| SCHEMBL14481975 | 0.72 | ALDH1A1 (0.64) | ALDH1A1CRHBPCRHR2MAOAKMO | |
| SCHEMBL2939094 | 0.72 | TDP1 (0.53) | ALDH1A1CYP3A4TDP1MAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113896607-B | Olefin oligomerization process using a catalyst comprising a chromium complex having a phosphacycle-containing ligand | 陶氏环球技术有限责任公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20220176363-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-06-09 | — | — | US | disclosed |
| CN-107548385-B | Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand | 陶氏环球技术有限责任公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113896607-A | Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand | 陶氏环球技术有限责任公司 | 2022-01-07 | — | — | CN | disclosed |
| CN-107592863-B | Chromium complexes with ligands containing phosphacycles and olefin oligomerization catalysts therefrom | 陶氏环球技术有限责任公司 | 2021-09-10 | — | — | CN | disclosed |
| CN-107567355-B | Phosphacycle-containing ligands for chromium complexes and olefin oligomerization catalysts therefrom | 陶氏环球技术有限责任公司 | 2021-07-23 | — | — | CN | disclosed |
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-05-06 | — | — | US | disclosed |
| US-10981156-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-04-20 | — | — | US | disclosed |
| US-10919031-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-02-16 | — | — | US | disclosed |
| US-20200338542-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-10-29 | — | — | US | disclosed |
| US-10702861-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-07-07 | — | — | US | disclosed |
| US-20200030783-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-01-30 | — | — | US | disclosed |
| US-10376869-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-08-13 | — | — | US | disclosed |
| US-10357764-B2 | Phosphacycle compound and process for production thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-23 | — | — | US | disclosed |
| US-20190210013-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-11 | — | — | US | disclosed |
| US-10207262-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-02-19 | — | — | US | disclosed |
| US-20180154344-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-06-07 | — | — | US | disclosed |
| US-20180071725-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | ALDH1A1 4182/4885CRHBP 2180/4885CRHR2 3230/4885 |
| US-20200338542-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | ALDH1A1 4182/4885CRHBP 2180/4885CRHR2 3230/4885 |
| US-20180071725-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | OXER1, LIG1, PICALM | ALDH1A1 4013/4885CRHBP 2678/4885CRHR2 2133/4885 |
| US-10919031-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | ALDH1A1 4182/4885CRHBP 2180/4885CRHR2 3230/4885 |
| US-10376869-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | ALDH1A1 4182/4885CRHBP 2180/4885CRHR2 3230/4885 |
| US-10981156-B2 | Chromium complex and catalyst therefrom | OXER1, LIG1, PICALM | ALDH1A1 4013/4885CRHBP 2678/4885CRHR2 2133/4885 |
| US-10357764-B2 | Phosphacycle compound and process for production thereof | OXER1, PPIP5K2, IP6K1 | ALDH1A1 4091/4885CRHBP 2306/4885CRHR2 2690/4885 |
| US-10207262-B2 | Chromium complex and catalyst therefrom | OXER1, LIG1, PICALM | ALDH1A1 4013/4885CRHBP 2678/4885CRHR2 2133/4885 |
| US-20200030783-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | ALDH1A1 4182/4885CRHBP 2180/4885CRHR2 3230/4885 |
| US-20180154344-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | ALDH1A1 4182/4885CRHBP 2180/4885CRHR2 3230/4885 |
| US-20220176363-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | ALDH1A1 4182/4885CRHBP 2180/4885CRHR2 3230/4885 |
| US-20190210013-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | OXER1, LIG1, PICALM | ALDH1A1 4013/4885CRHBP 2678/4885CRHR2 2133/4885 |
| US-10702861-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | ALDH1A1 4182/4885CRHBP 2180/4885CRHR2 3230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.